The global pharmaceutical industry: Changing competitive landscape

International Journal of Technology Management

Volumn 25, Issue 3-4, 2003, Pages 201-226

  Bowonder, B ^a   Thomas, Manoj T ^a   Rokkam, Vamshi Mohan ^b   Rokkam, Artie ^c  

^a ADMINISTRATIVE STAFF COLLEGE OF INDIA   (India)

^b Cinoni Inc   (India)

^c DR REDDY'S LABORATORIES LTD   (India)

Author keywords

Biotechnology; Globalisation; Innovation and technology platforms; Pharmaceutical industry

Indexed keywords

BIOTECHNOLOGY; COMPETITION; CONSOLIDATION; HEALTH CARE;

GLOBAL MARKET;

DRUG PRODUCTS PLANTS;

EID: 0037219890     PISSN: 02675730     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJTM.2003.003098     Document Type: Review

References (24)

1. Bowonder, B., Yadav, P.S. and Krishnan, S. (2001) 'Emerging technology trajectory of biotechnology firms', Chemical Innovation, Vol. 31, No. 3.
2. Enriquez, J. and Goldberg, R.A.O. (2000) 'Transforming business: the life science revolution', Harvard Business Review, Vol. 78, No. 2, pp.96-104.
3. Barret, A. (2001) Drugs. Business Week, Asian Edition, Vol. 3698, 1028, pp.80-81.
4. Pharmaceutical Research and Manufacturers of America (2000) 'Pharmaceutical industry profile 2000', PhRMA, Washington D.C, www.phrma.org
5. IMS (2000) Industry Report, www.imshealth.com
6. Reich, M.R. (2000) 'The global drug gap', Science, Vol. 287, pp.1979-1981.
7. Agnew, B. (2000) 'When pharma merges, R&D is the dowry', Science, Vol. 287, pp.1952-1953.
8. Bowonder, B., Yadav, P.S. and Kumar, S.B. (2000) 'R&D spending patterns of global firms', Research-Technology Management, Vol. 43, No. 5, pp.40-56.
9. ABN AMRO (2000) 'US drug industry', ABN AMRO, Chicago.
10. Financial Times (2000) 'R&D expenditure of top 300 companies by sector', 15 September, London.
11. Tyler, V.E. (1997) 'The herbal remedies market', Chemtech. Vol. 27, No. 5, pp.52-56.
12. Glassman. R. and Philip, M. (1999) 'The next generation of technology platforms in pharmaceutical discovery', in Building for Value from Discovery to Launch, Mckinsey.
13. James, B.G. (1994) 'The pharmaceutical industry in 2000'. The Economic Intelligence Unit, The Economist Group, London.
14. Coopers & Lybrand (1997) 'Pharmaceuticals: creating value by transferring the cost base', Coopers & Lybrand Industry, Report, www.colybrand.com.
15. Drews, J. (2000) 'Drug discovery: a historical perspective', Science, Vol. 287, pp.1960-1964.
16. Schreiber, S.L. (2000) 'Target oriented & diversity oriented organic synthesis in drug discovery', Science, Vol. 287, pp. 1964-1969.
17. Thayer, A.M. (1998) 'Chasing the innovation wave', Chemical and Engineering News, Vol. 77, No. 6, pp.17-22.
18. Standard & Poor (1996) Healthcare: Pharmaceuticals Industry Survey, 29 August, Standard and Poor, New York.
19. Baatz, E.B. (1999) 'Preparing for change: the pharmaceutical industry', www.cio.com.
20. Ryneki, D. (2000) 'Biotech's wonder ride', Fortune, Vol. 141, No. 5, pp. 153-154.
21. www.incyte.com.
22. Rogers, R.S. (1998) 'Battling for blockbusters', Chemical and Engineering News, Vol. 77, No. 7, pp.22-28.
23. Berggren, R. and Krinke, L. (1996) 'Elevating performance in drug discovery', in Raising Innovation to New Heights in Pharmaceutical Research, McKinsey, Chicago.
24. www.SignalsMag.com